当前位置: 首页 > 期刊 > 《中国医药实践杂志》 > 2014年第8期
编号:12809167
静脉滴注国产左西孟旦治疗急性失代偿性心力衰竭患者的疗效分析(3)
http://www.100md.com 2014年8月1日 高峡 张海东 张海燕
第1页

    参见附件。

     [2] 韦庆锋,吴慧,王雪静. 有创-无创序贯机械通气治疗急性左心衰竭的临床观察[J]. 广西医学,2012,34(5): 583-585.

    [3] Innes CA, Wagstaff AJ. Levosimendan: a review of its use in the management of acute decompensated heart failure[J]. Drugs, 2003, 63(11): 2651-2671.

    [4] Follath F, Cleland JG, Just H, et a1. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure(the LIDO study): a randomised double-blind tria1[J]. Lancet, 2002, 360(1): 196-202.

    [5] Nieminen MS, Akkila J, HasenfuSS G, et a1. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure[J]. J Am Coil Cardiol, 2000, 36(7): 1903-1912.

    [6]张红颖,蔡亚军,李春燕,等. 厄贝沙坦治疗老年射血分数正常心力衰竭24例效果观察[J]. 解放军医药杂志,2012,24(3): 37-38.

    [7] Mebazaa A, Nieminen M, Packer M, et a1. Levosimendan VS dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial[J]. JAMA, 2007, 297(6): 1883-1891.

    [8] Parissis JT, Panou F, Farmakis D. et a1. Effects of 1evosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure[J]. Am J Cardi01. 2005, 96(3): 423-426.

您现在查看是摘要介绍页,详见PDF附件